Medicare utilization — DR. ALESSANDRA ANNA SECCO (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J0878 | Injection, daptomycin, 1 mg | 47,915 | 20 | $0 | $1,950 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,510 | 12 | $0 | $88,822 |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 807 | 366 | $0 | $78,978 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 384 | 13 | $0 | $153 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 384 | 199 | $0 | $24,827 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·